,Gene,Gene synonym,Ensembl,Gene description,Chromosome,Position,Protein class,Evidence,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Prognostic p-value,RNA cancer category,RNA tissue category,RNA TS,RNA TS TPM,TPM max in non-specific,RNA cell line category,RNA CS,RNA CS TPM
0,ECEL1,"DINE, XCE",ENSG00000171551,Endothelin converting enzyme like 1,2,232479827-232487828,"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins",Evidence at protein level,"HPA067560, HPA069756",,Supported,Approved,Nucleoplasm<br>Nuclear membrane<br>Nucleoli,,Tissue enhanced,Tissue enriched,25,ovary: 111.9,spleen: 4.4,Group enriched,7.0,AN3-CA: 40.8;HeLa: 15.2
1,WFIKKN2,"WFDC20B, WFIKKNRP",ENSG00000173714,"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2",17,50834650-50842348,"Predicted intracellular proteins, Predicted secreted proteins",Evidence at protein level,,,,,,,Group enriched,Tissue enriched,17,ovary: 76.5,testis: 4.4,Not detected,,
2,CRYGD,CRYG4,ENSG00000118231,Crystallin gamma D,2,208121607-208124501,"Disease related genes, Predicted intracellular proteins",Evidence at protein level,HPA041269,,,Approved,Plasma membrane<br>Intermediate filaments<br>Cytokinetic bridge,,Tissue enhanced,Tissue enriched,13,ovary: 21.6,bone marrow: 1.6,Cell line enriched,17.0,HEL: 19.0
3,KLHDC8A,FLJ10748,ENSG00000162873,Kelch domain containing 8A,1,205336065-205357090,Predicted intracellular proteins,Evidence at transcript level,,,,,,Thyroid cancer:8.01e-4 (favourable),Tissue enhanced,Tissue enriched,11,ovary: 288.4,adrenal gland: 26.0,Group enriched,7.0,AF22: 4.1;HAP1: 8.9;NTERA-2: 2.1;SCLC-21H: 10.2
4,ARX,"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS",ENSG00000004848,Aristaless related homeobox,X,25003694-25016420,"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors",Evidence at protein level,,,,,,Endometrial cancer:3.54e-7 (unfavourable),Mixed,Tissue enriched,7,ovary: 97.7,testis: 14.0,Cell line enhanced,,HAP1: 2.0;PC-3: 3.6;U-266/70: 6.3
5,MUM1L1,FLJ33516,ENSG00000157502,MUM1 like 1,X,106168305-106208956,Predicted intracellular proteins,Evidence at protein level,"HPA000168, HPA020464",Enhanced,,,,Thyroid cancer:5.95e-4 (unfavourable),Mixed,Tissue enriched,7,ovary: 226.8,testis: 33.9,Cell line enhanced,,AF22: 2.9;HSkMC: 2.1;LHCN-M2: 4.6;NTERA-2: 2.1;T-47d: 1.7
